STAT Plus: Drug makers seek to curtail discounts paid to hospitals as part of a controversial federal program
The moves would hinder access for people who have difficulty affording their medicines and also violate federal law says Maureen Testoni of 340B Health.
No hay comentarios:
Publicar un comentario